Age (years), median (IQR) | 64.3 (52.1-73.5) |
Follow-up time monthsa, median (IQR) | 18.4 (10.5-26.1) |
Gender | |
 Male | 3165/5307 (59.6%) |
 Female | 2142/5307 (40.4%) |
ECOG performance status | |
 0 | 2374/3925 (60.5%) |
 1 | 1110/3925 (28.3%) |
 2 | 279/3925 (7.1%) |
 3 | 119/3925 (3.0%) |
 4 | 43/3925 (1.1%) |
Diagnosis | |
 Diffuse large B cell lymphoma (DLBCL) | 1717/5314 (32.3%) |
 Follicular lymphoma | 816/5314 (15.4%) |
 Other B cell non-Hodgkin lymphoma | 909/5314 (17.1%) |
 Hodgkin Lymphoma | 751/5314 (14.1%) |
 Chronic lymphocytic leukaemia (CLL) | 560/5314 (10.5%) |
 T-cell non-Hodgkin lymphoma | 283/5314 (5.3%) |
 Mantle cell lymphoma | 249/5314 (4.7%) |
 Post-transplant lymphoproliferative disease | 29/5314 (0.5%) |